| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |